Zymeworks Inc. (ZYME)

05:53 AM

EcoR1 Capital LLC Increases Stake in Zymeworks Inc. $ZYME - MarketBeat

05:53 AM

01:29 AM

Zymeworks Inc. (NYSE:ZYME) Receives Average Rating of "Buy" from Brokerages - MarketBeat

01:29 AM

Dec 12, 2025

Zymeworks (ZYME) Receives Rating Upgrade and Increased Price Tar - GuruFocus

Dec 12, 2025

Dec 12, 2025

Redmile Group LLC Sells 638,318 Shares of Zymeworks Inc. $ZYME - MarketBeat

Dec 12, 2025

Dec 11, 2025

Could Zymeworks' blockbuster drug success revive Vancouver biotech scene? - Delta Optimist

Dec 11, 2025

Dec 11, 2025

Norges Bank Buys New Shares in Zymeworks Inc. $ZYME - MarketBeat

Dec 11, 2025

Dec 09, 2025

Zymeworks to Engage in Key Investor Conferences - MSN

Dec 09, 2025

Dec 09, 2025

Zymeworks (ZYME) Is Up 5.2% After First FDA Approval For Zanidatamab And Royalty ShiftHas The Bull Case Changed? - Sahm

Dec 09, 2025

Dec 07, 2025

Zymeworks (ZYME): Reassessing Valuation After FDA Zanidatamab Approval and a Sharp Share Price Rally - Sahm

Dec 07, 2025

Dec 06, 2025

Zymeworks Inc Stock Analysis and ForecastPrice Momentum Alerts & Low Entry Investment Plans - earlytimes.in

Dec 06, 2025

Dec 05, 2025

How higher bond yields impact Zymeworks Inc. (ZA8) stockPortfolio Update Report & Weekly Setup with ROI Potential - Newser

Dec 05, 2025

Dec 05, 2025

Is Zymeworks Inc. (ZA8) stock cheap vs fundamentalsPortfolio Value Report & Long Hold Capital Preservation Tips - Newser

Dec 05, 2025

Dec 04, 2025

What technical patterns form on Zymeworks Inc. (ZA8) stock chartsWeekly Gains Summary & Short-Term Swing Trade Alerts - Newser

Dec 04, 2025

Dec 04, 2025

Is Zymeworks Inc. (ZA8) stock considered safe havenInsider Selling & AI Powered Market Trend Analysis - Newser

Dec 04, 2025

Dec 04, 2025

Will Zymeworks Inc. (ZA8) stock maintain strong growth2025 Earnings Impact & Safe Capital Allocation Plans - Newser

Dec 04, 2025

Dec 03, 2025

Zymeworks to Showcase Innovative Biotherapeutics at Upcoming Conferences - MSN

Dec 03, 2025

Dec 03, 2025

Citizens Initiates Coverage of Zymeworks (ZYME) with Market Outperform Recommendation - Nasdaq

Dec 03, 2025

Dec 03, 2025

How Zymeworks Inc. (ZA8) stock performs in volatility spikesJuly 2025 Gainers & Verified Technical Signals - Newser

Dec 03, 2025

Dec 02, 2025

Zymeworks Announces Participation in Upcoming Conferences - The Manila Times

Dec 02, 2025

Dec 02, 2025

Zymeworks Inc. Announces Participation in ASCO GI and J.P. Morgan Healthcare Conference, Highlighting Advances in HER2-Driven Gastrointestinal Cancers and Novel Drug Developments - Quiver Quantitative

Dec 02, 2025

Dec 02, 2025

Is Zymeworks Inc. (ZA8) stock supported by strong fundamentalsAnalyst Upgrade & Accurate Intraday Trade Tips - Newser

Dec 02, 2025

Dec 01, 2025

Universal Beteiligungs und Servicegesellschaft mbH Takes Position in Zymeworks Inc. $ZYME - MarketBeat

Dec 01, 2025

Nov 30, 2025

Zymeworks (ZYME) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - MSN

Nov 30, 2025

Nov 29, 2025

Is Zymeworks Inc a good long term investmentMarket Capitalization Trends & Join a Community of Smart Investors - earlytimes.in

Nov 29, 2025

Nov 29, 2025

Zymeworks Inc. $ZYME Stock Position Lifted by Tejara Capital Ltd - MarketBeat

Nov 29, 2025

Nov 28, 2025

Zymeworks (ZYME) Is Up 13.8% After Positive Zanidatamab Trial and Share Buyback PlanWhat's Changed - simplywall.st

Nov 28, 2025

Nov 27, 2025

Zymeworks (NASDAQ:ZYME) Stock Price Up 8%Time to Buy? - MarketBeat

Nov 27, 2025

Nov 27, 2025

Zymeworks (NYSE:ZYME) Trading Up 6.1%Here's Why - MarketBeat

Nov 27, 2025

Nov 27, 2025

Zymeworks Stock Sees Surge In Retail Chatter After Royalty Pivot, Cancer Trial Win Sparks Target Price Hikes - MSN

Nov 27, 2025

Nov 26, 2025

Zymeworks (NYSE:ZYME) Hits New 1-Year HighTime to Buy? - MarketBeat

Nov 26, 2025

Nov 26, 2025

A Look at Zymeworks (ZYME) Valuation Following $125M Buyback and Positive Zanidatamab Phase 3 Results - Sahm

Nov 26, 2025

Nov 25, 2025

Zymeworks Inc. (NYSE:ZYME) Q1 2025 Earnings Call Transcript - MSN

Nov 25, 2025

Nov 25, 2025

Zymeworks stock hits 52-week high at 26.2 USD By Investing.com - Investing.com Nigeria

Nov 25, 2025

Nov 25, 2025

Zymeworks (NYSE:ZYME) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat

Nov 25, 2025

Nov 25, 2025

Zymeworks (NASDAQ:ZYME) Sees Large Volume IncreaseHere's Why - MarketBeat

Nov 25, 2025

Nov 25, 2025

Zymeworks stock hits 52-week high at 26.2 USD - Investing.com

Nov 25, 2025

Nov 25, 2025

Zymeworks Inc.Common Stock (Nasdaq:ZYME) Stock Quote | PRN_FinancialWrapper | PR Newswire - Markets Financial Content

Nov 25, 2025

Nov 25, 2025

Zymeworks Announces Participation in Upcoming Investor Conferences - lelezard.com

Nov 25, 2025

Nov 24, 2025

Shareholder Miller Files To Sell 118,000 Of Zymeworks Inc [ZYME] - TradingView

Nov 24, 2025

Nov 24, 2025

Hillsdale Investment Management Inc. Lowers Stake in Zymeworks Inc. $ZYME - MarketBeat

Nov 24, 2025

Nov 24, 2025

Zymeworks Inc. Management to Participate in Upcoming Investor Conferences in Miami - Quiver Quantitative

Nov 24, 2025

Nov 24, 2025

Zymeworks (NASDAQ: ZYME) to Join Evercore, Citi 2025 Healthcare Conferences - Stock Titan

Nov 24, 2025

Nov 24, 2025

Zymeworks wanted to be Canada’s first Big Pharma. Despite two blockbusters-in-the-making, that’s no longer the plan - The Globe and Mail

Nov 24, 2025

Nov 24, 2025

Zymeworks Inc. (NASDAQ:ZYME) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Nov 24, 2025

Nov 22, 2025

Press Release: Zymeworks Announced Positive Phase 3 HERIZON-GEA-01 Results - Oncodaily

Nov 22, 2025